ketorolac (Orexo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameketorolac (Orexo)
Drug Alias NameNSAID (Orexo)ketorolacketorolac (Orexo)OX-338
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThioredoxin reductase 1 inhibitorsCyclooxygenases inhibitors
TargetsThioredoxin reductase 1Cyclooxygenases
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrexo AB
China Registration ClassN/A

Develop Information

Active CompaniesOrexo AB
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A